Product Information
LEI401 is a drug that inhibits the Wnt/β-catenin signaling pathway. LEI401 has been shown to inhibit the growth of cancer cells in vitro and in animal models. It also shows efficacy against other types of cancers, such as leukemia and lymphoma, with possible applications for treatments of tumors. LEI401 is currently under investigation for its potential to treat Alzheimer's disease and Huntington's disease. In addition, LEI401 has been shown to have anthelmintic activity against nematodes (roundworms). The drug targets proteasomes in nematodes and causes premature protein degradation, leading to cell death.
Chemical properties
Technical inquiry about: 3D-BL178105 LEI401
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
